MENU

  Home  
  For Patients  
  For Professionals  
  Who We Are  
  Contact Us  
     
 

back

 
     
  Click to visit the University of Toronto website  
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MENU

Home :: For Patients :: For Professionals :: Who We Are :: Contact Us

 

Research and Investigation:

Research Funding - Peer Reviewed:

  • Scholarship. Wallace MC: Canadian Heart and Stroke Foundation ($200,000 1989 - 1994)

  • Hemodynamic monitoring of patients with brain vascular malformations. Wallace MC, Ter Brugge KG, Willinsky RA: Physicians Services Incorporated Foundation ($25,000 1992 - 1994)

  • Effect of transluminal angioplasty on vasospasm in dogs. Wallace MC, MacDonald RL, Montanera WJ: Physicians Services Incorporated Foundation ($24,000 1992 - 1994)

  • Physiology and treatment of ischemic neuronal injury by intracellular calcium chelation. Charlton MP, Wallace MC: Heart and Stroke Foundation of Ontario ($128,260 1993 - 1995)

  • Physiology and treatment of ischemic neuronal injury by intracellular calcium chelation. Charlton MP, Wallace MC: Heart and Stroke Foundation of Ontario ($160,000 1995 - 1998)

  • Tyrosine phosphorylation of GP180 after cerebral ischemia. Gurd J, Wallace MC: Heart and Stroke Foundation of Ontario ($85,000 1996 - 1998)

  • International subarachnoid aneurysm trial. Willinsky RA, Wallace MC: Medical Research Council of Canada ($32,400 1998 - 2001)

  • Neoangiogenesis in cerebral ischemia. Guha A, Wallace MC, Nagy A: Heart & Stroke Foundation of Ontario ($152,300 1998 - 2000)

  • Tyrosine phosphorylation and molecular organization of the NMDA receptor following transient globalischemia: Implications for neuronal survival. Gurd J, Wallace MC: Heart & Stroke Foundation of Ontario ($230,700 1998 - 2001)

Research Funding - Non Peer Reviewed:

  • Pathophysiology of focal cerebral ischemia. Wallace MC: The Toronto Hospital/Department of Surgery ($75,000 1988 - 1989)

  • Magnetic resonance imaging of the evolution of experimental cerebral ischemia in the rat. Wallace MC: Dean's Fund, University of Toronto ($7,600 1989 - 1990)

  • In vitro 3H-Forskolin binding following focal cerebral ischemia. Wallace MC: Research Foundation, American Association of Neurological Surgeons ($40,000 1990 - 1991)

  • A model of embolic stroke in the rabbit. Wallace MC, Montanera WJ: Banting and Best Foundation ($14,300 1990 - 1991)

  • Neuronal protection in cerebral ischemia by intracellular calcium chelation. Wallace MC, Charlton MP, Tymianski M, Carlen P, Tator CH: Allelix Biopharmaceuticals Incorporated ($100,000 1993 - 1994)

  • Wallace MC: Rothman, Benson & Hedges Incorporated ($25,000 1994 - 1999)

  • Neuroprotection with membrane-permeant calcium chelation. Wallace MC, Charlton M, Tator CH, Carlen P, Tymianski M: Ontario Technology Grant, Allelix Biopharmaceuticals Incorporated ($3,600,000 1995 - 1998)

Patents:

  • In vivo treatment of mammalian cells with a cell membrane permeant calcium buffer. Charlton MP, Tymianski M, Wallace MC, Carlen P, Tator CH: US patent application - office action. 1993